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Clarence C. Tam,1 Sarah J. O'Brien,2 David S. Tompkins,3 Frederick J. Bolton,4 Lisa Berry,5 Julie Dodds,6
Dalia Choudhury,5 Fenella Halstead,5 Miren Iturriza-Go´mara,5 Katherine Mather,4 Greta Rait,6,7 Alan Ridge,4
Laura C. Rodrigues,1 John Wain,5 Bernard Wood,4 James J. Gray,5,8 and the IID2 Study Executive Committeea
1Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine; 2School of Translational Medicine, University of
Manchester and Manchester Academic Health Science Centre; 3Health Protection Agency Regional Laboratory, Leeds; 4Health Protection Agency
Regional Laboratory, Manchester; 5Health Protection Agency Centre for Infections, London; 6Medical Research Council General Practice Research
Framework; 7Department of Primary Care and Population Health, University College London; and 8School of Medicine, Health Policy and Practice,
University of East Anglia, Norwich, United Kingdom
Background. Large-scale, prospective studies of infectious intestinal disease (IID) in developed countries
are uncommon. Two studies of IID incidence and etiology have been conducted in the United Kingdom: the
Infectious Intestinal Disease Study in England (IID1) in 1993–1996 and the Second Study of Infectious
Intestinal Disease in the Community (IID2) in 2008–2009. We examined changes in etiology and diagnostic
yield of IID cases over 15 years.
Methods. Fecal samples submitted by IID cases were examined for a range of bacterial, viral, and protozoal
pathogens using traditional and molecular microbiological methods. We calculated the percentage of
specimens positive for each organism based on traditional methods and on traditional and molecular methods
combined. We compared the distributions of organisms in the 2 studies.
Results. For pathogens investigated in both studies, 40% of fecal samples submitted by cases in IID2 were
positive compared with 28% in IID1. Viruses were most frequent among community cases in IID2. Campylobacter
was the most common bacterial pathogen among cases presenting to healthcare. Major differences between the 2
studies were increases in the detection of norovirus and sapovirus and a decline Salmonella.
Conclusions. Most fecal specimens were negative for the pathogens tested in both studies, so new strategies are
needed to close the diagnostic gap. Among known pathogens, effective control of norovirus, rotavirus, and
Campylobacter remain high priorities. The reduction in nontyphoidal salmonellosis demonstrates the success of
Europe-wide control strategies, notably an industry-led Salmonella control program in poultry in the United Kingdom.
In developed countries, infectious intestinal disease
(IID) is often perceived as a minor illness causing
substantial morbidity but low mortality. Yet disruption
to society and the economy is substantial and is es-
timated to be V345 million in The Netherlands [1],
A$343 million in Australia [2], and Can $3.7 billion
in Canada [3]. Food-borne illness costs the UK economy
approximately £1.5 billion annually [4]. In New Zealand
and the United States, the costs are NZ $216 million [5]
and $152 billion [6], respectively, which are enormous
sums for preventable diseases.
Few prospective studies of IID in developed coun-
tries have included a broad range of pathogens in
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unselected cases in the community or presenting to healthcare
[7, 8, 9, 10, 11, 12]. In the United Kingdom, 2 prospective,
population-based studies of IID incidence and etiology in the
community have been conducted, the Infectious Intestinal
Disease Study in England (IID1) in 1993–1996 [7] and the
Second Study of Infectious Intestinal Disease in the Com-
munity (IID2) in 2008–2009 [13, 14]. Both used identical
case definitions and similar methodologies. They afford
a unique opportunity to compare the etiology of IID in com-
munity and cases presenting to general practice (GP)
15 years apart.
METHODS
The methodologies of the IID1 and IID2 studies are detailed
elsewhere [13, 15]. The main features are summarized in Table 1.
Both studies included a community cohort and a healthcare
presentation study; the distribution of organisms among
community and GP cases was expected to differ because
symptom severity influences healthcare seeking [16, 17]. In
the cohort studies, we recruited individuals of all ages from
the population who were registered with participating GPs.
Participants reported weekly whether they had experienced
diarrhea and/or vomiting in the previous week. We asked
symptomatic individuals to complete a questionnaire and
provide a stool specimen, which they mailed directly to the
laboratory for microbiologic analysis. In the GP presentation
studies, we invited all IID cases who consulted with their GP
to complete a symptom questionnaire and provide a stool
specimen for microbiologic testing.
Case Definitions
In both studies, IID cases were people with loose stools or
clinically significant vomiting lasting ,2 weeks in the absence
of a known noninfectious cause and preceded by a symptom-
free period of 3 weeks. Vomiting was clinically significant if
Table 1. Summary of the Main Features of the Infectious Intestinal Disease Study in England and the Second Study of Infectious
Intestinal Disease in the Community
IID1 [7, 8, 15] IID2 [13, 14]
Geographical location England United Kingdom
Study duration August 1993–January 1996 April 2008–August 2009
Sampling frame MRC GPRF GPRF plus Primary Care
Research Networks
in England, Wales
and Scotland
Prospective cohort study
Number of practices recruited 70 88
Number of cohort participants recruited 9776 7033
Participation rate (%) 35 9
Method of follow-up Weekly postcard (100%) Email (63%) or weekly
postcard (37%)
Maximum period of follow-up, weeks 26 (2 cohorts) 52 (1 cohort)
Lost to follow-up (%) 59 9.5
Number of cases reporting symptoms 781 1201
Number of cases submitting specimens 761 782
Percentage of specimens from
cases aged ,5 years (%)
25.1 15.3
Median time (IQR) from illness onset
to specimen submission, days
1 (0–2) 1 (0–3)
General practice presentation study
Number of practices recruited 34 37
Number of cases meeting the case definition 4026 991
Number of cases submitting specimens 2962 874
Percentage of specimens from
cases aged ,5 years (%)
31.3 22.0
Median time (IQR) from illness onset to
specimen submission
4 (2–7) 6 (4–9)
Abbreviations: GPRF, General Practice Research Framework; IID1, Infectious Intestinal Disease Study in England; IID2, second Study of Infectious Intestinal
Disease in the Community; IQR, interquartile range; MRC, Medical Research Council.
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it occurred more than once in a 24-hour period and if it in-
capacitated the case or was accompanied by other symptoms
such as cramps or fever. Definite cases were those who met the
clinical definition, regardless of whether a causative organism
was identified. Probable cases were symptomatic individuals
for whom there was insufficient information to classify them
as definite cases.
A case of Clostridium difficile–associated diarrhea was an
individual aged $2 years with symptoms of diarrhea not
attributable to another cause (ie, the absence of other en-
teropathogens), occurring at the same time as a positive
toxin assay.
Exclusions
In both studies, people were excluded for the following
reasons because an infectious etiology and onset date for
acute symptoms could not be reliably determined: terminal
illness; severe mental incapacity; or recognized, noninfectious
causes of diarrhea or vomiting, including Crohn’s disease,
ulcerative colitis, cystic fibrosis, celiac disease, surgical ob-
struction, excess alcohol, morning sickness and, in infants, re-
gurgitation. Additional exclusions were non-English speakers
without a suitable translator and those traveling outside the
United Kingdom in the 10 days before onset of illness.
Microbiologic Testing in the Second Study of Infectious
Intestinal Disease in the Community
Cases mailed their sample directly to the Health Protection
Agency Regional Laboratory (Manchester) [13] in a kit com-
prising instructions for sample collection, a screw-top plastic
universal container with integral plastic spoon, a rigid plastic
outer container, a post office–compliant cardboard box, and
a strong plastic, postage-paid envelope. We used the following
methods:
d culture for Campylobacter jejuni/coli, Shiga toxin–producing
Escherichia coli (STEC) O157, Listeria monocytogenes,
nontyphoidal Salmonella spp., Shigella spp. and Yersinia spp.;
d enzyme immunoassay (EIA) for Clostridium perfringens
enterotoxin, Cryptosporidium parvum, and Giardia intestinalis;
d EIA and polymerase chain reaction (PCR) for C. difficile
cytotoxins A and B;
d Light microscopy examination of a stained smear for
Cyclospora and Cryptosporidium; and
d EIA for rotavirus and adenovirus 40, 41 (in samples from
children ,5 years of age).
Any samples that were immunoassay-positive for C. difficile
toxin or PCR-positive were cultured using National Stan-
dard Method BSOP 10 [13]. All C. difficile isolates were then
ribotyped [18].
All samples were then examined at the Health Protection
Agency Centre for Infections (London). We prepared 2
nucleic acid extracts from each sample [19, 20, 21]. We ex-
amined each extract using real-time PCR for C. jejuni, C. coli,
L. monocytogenes, nontyphoidal Salmonella spp., rotavirus,
norovirus, sapovirus, adenovirus, astrovirus, Cryptosporidium
(C. hominis, C. parvum, C. meleagridis, and C. felis), Giardia spp.,
and E. coli (enteroaggregative and Shiga toxin–producing [genes
encoding ST1 and ST2]).
We included DNA (phocine herpesvirus) and RNA (mouse
mengovirus) controls in each sample to monitor nucleic acid
extraction and reverse transcription. We used positive and
negative microbe-specific controls in each assay run to monitor
target-specific reagents. Controls were quantitative, enabling
use of Westgard rules to determine whether assays were within
3 standard deviations of the expected value and to determine
the coefficient of variation [22].
We considered a cycle threshold (CT) value ,40 to be
a positive result for all organisms except norovirus and ro-
tavirus. A considerable fraction of asymptomatic individuals
have low viral loads, yet test positive by reverse-transcription
PCR [23] among IID cases with low viral loads; therefore,
these organisms are unlikely to be responsible for symptoms
[24, 25]. A CT value ,30 for both viruses suggests a clinically
significant result; that is, disease truly caused by these 2 or-
ganisms [24, 25]. For rotavirus, this cutoff point coincides well
with positive enzyme-linked immunosorbent assay (ELISA)
results [25]. Therefore, a CT value ,30 defined clinically sig-
nificant norovirus and rotavirus infection.
Both laboratories were fully accredited and participated in
2 external quality audits during the IID2 Study.
Data Analysis
For the IID2 cohort and GP presentation components, we
computed by study the percentage of specimens positive for
each organism among IID cases with a stool sample available
for analysis. If a sample was positive for 2 organisms, we
counted it as positive in the calculations for both organisms
(except for C. difficile, as defined above). We computed the
percentage of specimens positive for each organism based on
routine diagnostic methods and on routine and molecular
diagnostic methods combined. We also calculated the per-
centage of specimens that were negative for all organisms
tested. For each percentage, we computed exact binomial
95% confidence intervals.
We compared the frequency of detection of each organism
between the IID2 and IID1 studies among cases ascertained
in England [8] using only the subset of organisms targeted in
both studies (Table 2). Thus, we investigated the additional
diagnostic yield achievable using molecular methods. Using
PCR methods in IID2 (not widely used in IID1), we expected
increased diagnostic yields, particularly for enteric viruses
[23, 24, 25]. For organisms tested by PCR in the IID2 study
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(Campylobacter, Salmonella, Cryptosporidium, Giardia, ade-
novirus, astrovirus, norovirus, rotavirus, and sapovirus), we
compared the percentage positivity using conventional
methods in IID1 with that using both conventional and PCR
methods in IID2 to establish the added benefit of using
molecular diagnostic methods. To account for the differing
distribution of pathogens in children and adults, we compared
the etiology of IID cases between the 2 studies in children aged
,5 years and in those aged $5 years.
We conducted all analyses in Stata 11.0 (StataCorp) and Excel
2007 software.
Ethics
We obtained a favorable ethical opinion from the National Health
Service North West Research Ethics Committee (07/MRE08/5).
RESULTS
Results of the IID2 Study
Among community cases, 75% of stool samples were sub-
mitted within 3 days of illness onset, compared with 9 days
among GP cases. In a logistic regression analysis (not shown),
only specimens submitted $10 days after onset were more
Table 2. Changes in Microbiological Protocols Between the Infectious Intestinal Disease Study in England and the Second Study of
Infectious Intestinal Disease in the Community
Bacteria Changes From IID1 Reasons for Changes From IID1
Aeromonas spp. Not tested No established techniques for identification of small
fraction of pathogenic strains; many positives in
controls in IID1
Arcobacter spp. Not tested Of doubtful pathogenicity and significance
Bacillus spp. Not tested Very few cases in IID1; difficult to confirm
pathogenicity in individual cases
Campylobacter spp. 2 of 3 selective methods not used in IID2 Very few positives of species other than C. coli and
C. jejuni detected in IID1
Clostridium difficile
cytotoxin
Commercial immunoassay to detect
toxins A and B replacing in-house
cytotoxin test
More practical and backed up by PCR
Clostridium perfringens Commercial immunoassay to
screen for enterotoxin
A more specific and meaningful test than
spore counts
Escherichia coli O157 Use CT-SMAC as selective medium CR-SMAC used in previous study; CT-SMAC
now in routine use
Listeria spp. Include as a new pathogen L. monocytogenes is 1 of the FSA’s target organisms
Plesiomonas shigelloides Not tested Very low numbers in IID1
Staphylococcus aureus Not tested Low numbers in IID1; similar numbers in
cases and controls
Vibrio spp. Not tested except in cases with history
of recent foreign travel
Frequency in UK too low for value in this study,
so only included for clinical necessity
Yersinia spp. Change of enrichment protocol Adopt HPA standard method for enrichment
Protozoa
Cryptosporidium parvum Commercial immunoassay and PCR
replacing light microscopy
Improve practicality and sensitivity
Giardia intestinalis Commercial immunoassay and PCR
replacing light microscopy
Improve practicality and sensitivity
Viruses
Adenovirus 40, 41 PCR assays replacing immunoassays and
electron microscopy
Improved sensitivity
Astrovirus PCR assays replacing immunoassays and
electron microscopy
Improved sensitivity
Rotavirus A and C PCR assays replacing immunoassays and
electron microscopy
Improved sensitivity
Norovirus PCR assays replacing immunoassays and
electron microscopy
Improved sensitivity
Sapovirus PCR assays replacing immunoassays and
electron microscopy
Improved sensitivity
Abbreviations: CR-SMAC, cefixime rhamnose sorbitol MacConkey agar; CT-SMAC, cefixime tellurite sorbitol MacConkey agar; FSA, Food Standards Agency; HPA,
Health Protection Agency; IID1, Infectious Intestinal Disease Study in England; IID2, second Study of Infectious Intestinal Disease in the Community; PCR,
polymerase chain reaction.
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likely to test negative for all pathogens tested after adjusting
for other factors.
Community Cases
Viruses were the most common organisms among community
cases; norovirus, sapovirus, and rotavirus infection were iden-
tified in 16.5%, 9.2%, and 4.1% of specimens, respectively (Table
3). Campylobacter was the most common bacterial agent; 4.6%
of specimens tested positive for Campylobacter by culture or PCR
(3.7% by culture alone). Enteroaggregative E. coli was found by
PCR in 1.9% of specimens. Other bacterial pathogens were
identified with a frequency of ,1%. No C. difficile–positive
specimens were identified using immunoassay methods. Overall,
60.2% of specimens were negative for all pathogens tested.
Cases Presenting to the General Practitioner
Campylobacter (13.0%) and norovirus (12.4%) were the most
common agents among GP cases (Table 4). By contrast, Sal-
monella was less common than C. perfringens, enteroaggregative
E. coli, Cryptosporidium spp., or Giardia intestinalis. Only
Table 3. Microbiological Findings in Cohort Cases in the Second Study of Infectious Intestinal Disease in the Community
Pathogen Test No. Identified Tested % Identified 95% CI
Bacteria
Clostridium difficilea All 1 715 0.1 (0–0.8)
EIA 0 715 0.0 (0–0.5)
PCR 1 693 0.1 (0–0.8)
Clostridium perfringens Toxin 6 772 0.8 (0.3–1.7)
Campylobacter All 36 782 4.6 (3.2–6.3)
All culture 28 767 3.7 (2.4–5.2)
Direct culture 18 766 2.3 (1.4–3.7)
Enrichment 27 766 3.5 (2.3–5.1)
PCR 31 782 4.0 (2.7–5.6)
Escherichia coli O157 STEC Culture 1 768 0.1 (0–0.7)
E. coli non–O157 STEC PCR 6 781 0.8 (0.3–1.7)
Enteroaggregative E. coli PCR 15 782 1.9 (1.1–3.1)
Listeria Culture and/or PCR 0 769 0.0 (0–0.5)
Salmonella All 2 782 0.3 (0–0.9)
Culture 2 768 0.3 (0–0.9)
PCR 1 782 0.1 (0–0.7)
Shigella Culture 0 768 0.0 (0–0.5)
Yersinia All culture 0 769 0.0 (0–0.5)
Direct culture 0 769 0.0 (0–0.5)
Enrichment 0 769 0.0 (0–0.5)
Protozoa
Cryptosporidium All 3 782 0.4 (0.1–1.1)
EIA 2 768 0.3 (0–.9)
PCR 3 782 0.4 (0.1–1.1)
Cyclospora Microscopy 0 768 0.0 (0–0.5)
Giardia All 6 782 0.8 (0.3–1.7)
EIA 3 768 0.4 (0.1–1.1)
PCR 6 782 0.8 (0.3–1.7)
Viruses
Adenovirus ELISA and/or PCRb 28 782 3.6 (2.4–5.1)
Astrovirus PCR 14 782 1.8 (1–3)
Norovirus PCR 129 782 16.5 (14–19.3)
Rotavirus ELISA and/or PCRb 32 782 4.1 (2.8–5.7)
Sapovirus PCR 72 782 9.2 (7.3–11.5)
No pathogen identified 471 782 60.2 (56.7–63.7)
Abbreviations: CI, confidence interval; EIA, enzyme immunoassay; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction; STEC, Shiga
toxin-producing Escherichia coli.
a Only specimens from cases aged $2 years were tested for Clostridium difficile.
b ELISA for adenovirus and rotavirus was conducted on specimens from cases aged ,5 years.
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0.1% had C. difficile toxin detected in the stool (by EIA).
Viruses were common among cases presenting to the GP. No
pathogen was identified in 48.6% of specimens.
Etiology of IID Cases in the Community and Presenting to the
General Practitioner in the IID2 Study
Campylobacter and rotavirus were more common among
GP cases than community cases (Figure 1). Norovirus was
more common among community cases, but was found in
.12% of GP cases. Smaller differences were seen for other
organisms, although the number of positive specimens was
low.
An additional 4.2% of community cases and 2.5% of GP
cases had norovirus CT values between 30 and 40, indicating
low-level subclinical viral shedding. For rotavirus the per-
centages were 5.6% and 5.2%, respectively.
Table 4. Microbiological Findings in General Practice Presentation Cases in the Second Study of Infectious Intestinal Disease in the
Community
Pathogen Test No. Identified Tested % Identified 95% CI
Bacteria
Clostridium difficilea All 10 738 1.4 (0.7–2.5)
EIA 1 736 0.1 (0–0.8)
PCR 9 719 1.3 (0.6–2.4)
Clostridium perfringens Toxin 19 868 2.2 (1.3–3.4)
Campylobacter All 114 874 13.0 (10.9–15.5)
All culture 69 866 8.0 (6.3–10)
Direct culture 48 866 5.5 (4.1–7.3)
Enrichment 65 863 7.5 (5.9–9.5)
PCR 105 874 12.0 (9.9–14.4)
E. coli O157 STEC Culture 1 866 0.1 (0–0.6)
E. coli non-O157 STEC PCR 7 866 0.8 (0.3–1.6)
Enteroaggregative Escherichia coli PCR 12 874 1.4 (0.7–2.4)
Listeria Culture and/or PCR 0 865 0.0 (0–0.4)
Salmonella All 7 874 0.8 (0.3–1.6)
Culture 7 866 0.8 (0.3–1.7)
PCR 6 874 0.7 (0.3–1.5)
Shigella Culture 0 866 0.0 (0–0.4)
Yersinia All 1 866 0.1 (0–0.6)
Direct culture 0 865 0.0 (0–0.4)
Enrichment 1 866 0.1 (0–0.6)
Protozoa
Cryptosporidium All 12 874 1.4 (0.7–2.4)
EIA 9 863 1.0 (0.5–2)
PCR 12 874 1.4 (0.7–2.4)
Cyclospora Microscopy 0 861 0.0 (0–0.4)
Giardia All 9 874 1.0 (0.5–1.9)
EIA 6 863 0.7 (0.3–1.5)
PCR 9 874 1.0 (0.5–1.9)
Viruses
Adenovirus ELISA and/or PCRb 30 874 3.4 (2.3–4.9)
Astrovirus PCR 22 874 2.5 (1.6–3.8)
Norovirus PCR 108 874 12.4 (10.2–14.7)
Rotavirus ELISA and/or PCRb 64 874 7.3 (5.7–9.3)
Sapovirus PCR 77 874 8.8 (7–10.9)
No pathogen identified 425 874 48.6 (45.3–52)
Abbreviations: CI, confidence interval; EIA, enzyme immunoassay; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction; STEC, Shiga
toxin-producing Escherichia coli
a Only specimens from cases aged 2 years and above were tested for C. difficile.
b ELISA for adenovirus and rotavirus was conducted in specimens from cases aged ,5 years.
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Mixed Infections
Infections with 2 or more organisms were identified in 37
(4.7%) community cases. These mixed infections primarily
involved adenovirus, norovirus, or sapovirus. Among GP
cases, 40 (4.6%) had mixed infections, the majority involving
adenovirus, norovirus, sapovirus, or Campylobacter.
Comparison of Organism Distributions in the IID1 and IID2
Studies in England
Norovirus and sapovirus were identified more frequently in
IID2 than in IID1, both among community cases (Figure 2) and
GP cases (Figure 3). Certain pathogens were less common
among GP cases presenting to the GP in IID2, most notably
enteroaggregative E. coli and Salmonella, but there were few
positive specimens for these organisms. There was also a notable
decrease in detection of Y. enterocolitica in IID2 relative to IID1.
Figure 4 compares the detection of different organisms
among children ,5 years (panel A) and those aged $5 years
(panel B) in community (blue circles) and GP cases (orange
circles) between IID1 and IID2. Organisms on the diagonal
were identified with similar frequency in both studies. Among
children ,5 years, the major differences between the 2 studies
were the greater detection of viral agents in IID2, particularly
norovirus and sapovirus, and the greater detection of bacterial
agents among community cases in IID1. In addition, E. coli non–
O157 STEC was identified more frequently among commu-
nity cases in IID2. Similarly, among cases aged $5 years,
norovirus, sapovirus, adenovirus, and E. coli non–O157
STEC were identified more frequently in IID2, both among
community and GP cases. However, Salmonella, C. perfringens,
E. coli O157 STEC, and enteroaggregative E. coli occurred more
frequently among both community and GP cases in IID1.
Clostridium difficile and astrovirus were also identified more
frequently among community cases in IID1.
In comparing the same set of organisms between the 2
studies, 40% of specimens from community cases had at least
1 organism detected in IID2 compared with 28% in IID1. For
cases aged ,5 years, the corresponding percentages were
60% and 48%, respectively. The difference between the 2
studies is primarily due to greater virus detection among
community cases in IID2 (Figure 5). Among GP cases, the
differences were less marked because the relative increase in
detection of viruses in IID2 was offset by the greater fre-
quency of bacterial agents identified in IID1.
DISCUSSION
In the IID2 study, norovirus was the most common viral agent
among community IID cases, and Campylobacter spp. was the
most common bacterial cause. A major difference between the
Figure 1. Microbiological findings in cohort and general practice presentation cases in the second Study of Infectious Intestinal Disease in the
Community. Abbreviations: GP, general practice; STEC, Shiga toxin-producing Escherichia coli.
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2 studies is the greater detection of viral agents, particularly
among cases for patients aged $5 years. In the IID2 study,
there is some evidence that adenovirus viral loads are higher
among children aged ,5 years (data not shown); use of PCR
enabled detection among older individuals with intermediate
viral loads that would likely have been missed in IID1. For
sapovirus, there is little evidence in our data for age-specific
differences in viral load or age-related differences in timing of
specimen submission. Increased detection of sapovirus in
older individuals is thus likely to reflect both greater sensi-
tivity of PCR and a change in the epidemiology of this or-
ganism; the high frequency of sapovirus coincided with the
introduction of a new genotype in the United Kingdom [26].
In general, bacterial agents were found less frequently in
IID2 than IID1. There might have been general decreases in
the incidence of certain pathogens or increases in other patho-
gens (such as sapovirus) that have driven down frequency of
detection of other agents.
Norovirus, sapovirus, and Campylobacter were common
among GP cases. The higher detection rate for norovirus and
sapovirus means that, even if small percentages result in GP
consultations, the absolute number of consultations is higher
than for other pathogens because both viruses are very com-
mon in the community. Campylobacter might result in more
severe illness, which also influences the likelihood of GP
consultation [16, 17], and could explain why detection was
more common among cases aged $5 years. Nevertheless,
norovirus and sapovirus were also common among GP cases in
this age group. Among community and GP cases, C. perfringens,
Salmonella spp., L. monocytogenes, E. coli O157 STEC, and C.
difficile were uncommon. The drop in salmonellosis between
IID1 and IID2 further reflects the success of the UK in-
dustry–led Salmonella control program in broiler-breeder
and laying poultry flocks [27]. The fall in Yersinia cases
might reflect improved slaughterhouse hygiene and/or de-
creased pork consumption following the foot-and-mouth disease
outbreaks in 2001 and 2007 [28].
Strengths and Limitations
Participation in the IID2 cohort was low (but comparable to
major concurrent UK cohort studies) and less than IID1
[14]. However, the low participation in IID2 was offset by
good compliance with weekly follow-up. Drop-outs among
participants were far fewer than in IID1.
The inclusion of molecular methods in IID2 enabled in-
vestigation of low-volume samples and increased the diagnos-
tic yield among community cases by around 10% compared
with IID1. The PCR methods particularly increased the
Figure 2. Microbiological findings among community cases of infectious intestinal disease in the Infectious Intestinal Disease Study in England and the
second Study of Infectious Intestinal Disease in the Community. Abbreviations: IID1, Infectious Intestinal Disease Study in England; IID2, second Study of
Infectious Intestinal Disease in the Community; STEC, Shiga toxin-producing Escherichia coli.
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sensitivity of virus detection. Similar increases in virus de-
tection were seen among GP cases, but the overall benefit was
offset by the greater detection of bacterial agents in IID1.
Specimens from asymptomatic individuals were not
available in IID2. Identifying an appropriate cutoff value to
define a positive PCR result is difficult without information
on CT value distributions among controls. We have shown
previously that a CT value of ,30 is a good indicator of IID
genuinely caused by norovirus and rotavirus [23, 24] and
therefore these definitions were used for clinically significant
norovirus and rotavirus infection here. Although viral loads
might be affected by late specimen collection, we found no
differences in CT values between specimens collected within
and after 3 days of illness onset (data available but not
shown) and made no adjustments for timing of specimen
collection. In the absence of similar data on CT value cutoffs
for other organisms, we used a more sensitive cutoff value
of,40 for other pathogens. We found good agreement between
PCR and culture results for both Campylobacter and Salmonella,
but might have overestimated incidence of other pathogens if
disease in IID cases with high CT values (low pathogen loads)
was not actually due to infection with those organisms.
Mixed infections were identified in less than 5% of speci-
mens. Without controls, it is difficult to determine whether
coinfection is coincidental, whether it is due to shared routes
of infection, or whether certain pairs of pathogens are more
often associated with disease (as opposed to asymptomatic
infection). The frequency of mixed infections in our study
might be lower than in other studies because we considered as
negative those norovirus and rotavirus specimens with low viral
loads that are unlikely to be responsible for clinical disease.
We detected only L. monocytogenes and C. difficile that was
diarrhea associated and so underestimated the clinical impact
of these infections. Furthermore, we did not collect data on
hospital stays or antibiotic usage that might aid interpretation
of C. difficile results.
Negative Stool Specimens
Using identical case definitions and a comparable set of or-
ganisms, an etiologic agent was detected in 40% of com-
munity cases in IID2 compared with ,30% in IID1. Among
GP cases, the diagnostic yield was around 50% in both studies.
A number of possible reasons exist for the high percentage of
cases with unknown etiology. First, we did not define the term
‘‘diarrhea’’ to participants; it is possible that individuals re-
ported transient changes in bowel habit not caused by IID.
Alternatively, these cases could be due to organisms not in-
cluded in our diagnostic algorithms, such as enteropathogenic
Figure 3. Microbiological findings among infectious intestinal disease cases presenting to general practice in the Infectious Intestinal Disease Study in
England and the second Study of Infectious Intestinal Disease in the Community. Abbreviations: IID1, Infectious Intestinal Disease Study in England; IID2,
second Study of Infectious Intestinal Disease in the Community; STEC, Shiga toxin-producing Escherichia coli.
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Figure 4. A, Percentage of specimens testing positive for different organisms among community and general practice cases for patients aged,5 years
in the Infectious Intestinal Disease Study in England (IID1) and the second Study of Infectious Intestinal Disease in the Community (IID2). B, Percentage of
specimens positive for different organisms among community and general practice cases for patients aged .5 years in the IID1 and IID2 studies,
England. Abbreviations: GP, general practice; IID1, Infectious Intestinal Disease Study in England; IID2, second Study of Infectious Intestinal Disease in
the Community; STEC, Shiga toxin-producing Escherichia coli.
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or enterotoxigenic E. coli. Three ‘‘new’’ bacterial etiologic
agents of diarrhea have been described recently [29]: Klebsiella
oxytoca, which appears to cause disease following perturba-
tion of the gut flora by antibiotic treatment, like C. difficile
[30]; enterotoxigenic Bacteroides fragilis in children [31]; and
Laribacter hongkongensis [32]. Similarly, several viruses have
been proposed as causes of IID (particularly in children),
including coronaviruses, picobirnaviruses, pestiviruses, and
toroviruses [33]. Recently, interest has been focused on the
parvoviruses. At least 3 human bocaviruses (HBoV) have
been associated with IID, and 1 Australian study identified
human bocavirus 2 in 17.2% of children with IID compared
with 8.1% of controls [34].
CONCLUSIONS
The major change in pathogen distribution between IID1
and IID2 was a drop in Salmonella cases, indicating the
success of European-wide interventions and, notably, an
industry-led Salmonella control program in chickens in the
United Kingdom. However, the majority of stool specimens
submitted in both studies by cases were negative for patho-
gens included in our diagnostic panel. New-generation
sequencing techniques [35, 36], though not yet adapted for
widespread use [37], afford immense opportunities to identify
novel pathogens to close the diagnostic gap. Among the
known pathogens, effective control of norovirus, rotavirus,
and Campylobacter infections remains a high priority in the
meantime.
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